Pennsylvania
|
000-00121
|
23-1498399
|
||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
No.)
|
1005
Virginia Drive, Fort Washington, PA
|
19034
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
·
|
six
months of the officer’s base salary in effect on the last day of the
officer’s employment, provided however, if the officer enters into a
general release in favor of the Company, the Company will instead pay 18
months base salary;
|
·
|
continuation
of medical, prescription drug, dental, and vision benefits, including for
covered dependents, for six months following the last day of the officer’s
employment (or for an aggregate of 18 months if the officer has delivered
a general release) at the same contribution rate as active
employees;
|
·
|
continuation
of eligibility to participate in the Company’s life insurance program for
a maximum of six months after the last day of the officer’s employment if
permitted by the life insurance provider;
and
|
·
|
any
earned quarterly cash incentive award for a fiscal quarter only if the
officer’s last day of employment is on or after the last day of such
fiscal quarter.
|
·
|
termination
pay equal to the benefit multiple assigned to the officer times the sum of
the officer’s annual base salary and certain incentives (the “Benefit
Amount”) provided that any Benefit Amount may be reduced to $10 less than
the amount which would subject the officer to excise tax with respect to
such payment under Section 4999 of the Internal Revenue Code (the “Code”)
or would make payment thereof non−deductible by the Company under Section
280G of the Code;
|
·
|
continuation
of medical, prescription drug, dental, and vision benefits for number of
months for which the Benefit Amount is payable for the officer, officer’s
spouse and dependent children at the same premium rate as in effect prior
to the officer’s termination date;
and
|
·
|
continuation
of eligibility to participate in the Company’s life insurance program for
a maximum of six months after the last day of the officer’s employment if
permitted by the life insurance
provider.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit
No.
|
Description
|
10.1
|
Kulicke
and Soffa Industries, Inc. Officer Severance Pay
Plan.
|
10.2
|
Form
of Change of Control Agreement.
|
March
31, 2009
|
KULICKE
AND SOFFA INDUSTRIES, INC.
|
||
|
By:
|
/s/ Maurice E. Carson | |
Name: | Maurice E. Carson | ||
Title: | Senior Vice President, Chief Financial Officer | ||